Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

2 structures for Q9QX29

Entry ID Method Resolution Chain Position Source
6AEI EM 289 A A/B/C/D 1-765 PDB
AF-Q9QX29-F1 Predicted AlphaFoldDB

51 variants for Q9QX29

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3412458735 6 Y>H No EVA
rs3389577093 16 D>Y No EVA
rs3389544281 29 L>M No EVA
rs3412458739 38 S>G No EVA
rs3410789984 82 N>Y No EVA
rs3389557499 86 M>L No EVA
rs3412190668 103 A>LLADGVE* No EVA
rs3389544244 109 V>I No EVA
rs3389570937 122 S>N No EVA
rs3412374251 131 M>V No EVA
rs3409508079 133 D>N No EVA
rs3412374225 195 S>Y No EVA
rs3412374236 240 E>Q No EVA
rs3412151381 242 E>* No EVA
rs3412457615 247 Q>P No EVA
rs3389588098 304 Q>L No EVA
rs3412188539 310 L>G No EVA
rs3389577852 323 R>P No EVA
rs3412051190 324 R>K No EVA
rs3389570985 329 V>I No EVA
rs3389485936 339 F>L No EVA
rs3389591089 387 H>R No EVA
rs3389581187 400 P>L No EVA
rs3389577827 431 I>T No EVA
rs3389571355 534 G>V No EVA
rs3389573364 543 E>A No EVA
rs3389571413 547 I>F No EVA
rs3389527432 568 L>I No EVA
rs3389577817 633 D>N No EVA
rs3411813262 652 D>G No EVA
rs3412372323 655 G>A No EVA
rs3389578358 656 T>A No EVA
rs3411813292 700 T>I No EVA
rs3389535050 713 Y>N No EVA
rs3389588070 717 I>M No EVA
rs3411400402 727 A>S No EVA
rs3389527374 760 L>H No EVA
rs3411813257 790 G>R No EVA
rs3410787488 802 V>L No EVA
rs3411400330 808 A>T No EVA
rs3411400380 808 A>V No EVA
rs3389585802 820 R>I No EVA
rs253553874 824 A>T No EVA
rs3389573329 876 H>N No EVA
rs29282906 877 C>Y No EVA
rs3389588023 887 M>K No EVA
rs29282908 899 Q>E No EVA
rs3412151698 919 E>K No EVA
rs3389557526 921 P>T No EVA
rs3412279076 965 D>G No EVA
rs3389544214 969 E>A No EVA

No associated diseases with Q9QX29

4 regional properties for Q9QX29

Type Name Position InterPro Accession
repeat Ankyrin repeat 38 - 118 IPR002110-1
repeat Ankyrin repeat 141 - 170 IPR002110-2
domain Ion transport domain 376 - 635 IPR005821
domain Transient receptor ion channel domain 176 - 238 IPR013555

Functions

Description
EC Number
Subcellular Localization
  • Cell membrane ; Multi-pass membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

8 GO annotations of cellular component

Name Definition
calcium channel complex An ion channel complex through which calcium ions pass.
cation channel complex An ion channel complex through which cations pass.
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
dendrite A neuron projection that has a short, tapering, morphology. Dendrites receive and integrate signals from other neurons or from sensory stimuli, and conduct nerve impulses towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body.
growth cone The migrating motile tip of a growing neuron projection, where actin accumulates, and the actin cytoskeleton is the most dynamic.
integral component of plasma membrane The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
membrane raft Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
neuronal cell body The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites.

7 GO annotations of molecular function

Name Definition
actin binding Binding to monomeric or multimeric forms of actin, including actin filaments.
actinin binding Binding to actinin, any member of a family of proteins that crosslink F-actin.
ATPase binding Binding to an ATPase, any enzyme that catalyzes the hydrolysis of ATP.
calcium channel activity Enables the facilitated diffusion of a calcium ion (by an energy-independent process) involving passage through a transmembrane aqueous pore or channel without evidence for a carrier-mediated mechanism.
clathrin binding Binding to a clathrin heavy or light chain, the main components of the coat of coated vesicles and coated pits, and which also occurs in synaptic vesicles.
inositol 1,4,5 trisphosphate binding Binding to inositol 1,4,5 trisphosphate.
store-operated calcium channel activity A ligand-gated ion channel activity which transports calcium in response to emptying of intracellular calcium stores.

13 GO annotations of biological process

Name Definition
calcium ion transmembrane transport A process in which a calcium ion is transported from one side of a membrane to the other by means of some agent such as a transporter or pore.
manganese ion transport The directed movement of manganese (Mn) ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
negative regulation of dendrite morphogenesis Any process that stops, prevents, or reduces the frequency, rate or extent of dendrite morphogenesis.
neuron apoptotic process Any apoptotic process in a neuron, the basic cellular unit of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the nervous system.
neuron differentiation The process in which a relatively unspecialized cell acquires specialized features of a neuron.
phosphatidylserine exposure on apoptotic cell surface A phospholipid scrambling process that results in the appearance of phosphatidylserine on the outer leaflet of the plasma membrane of an apoptotic cell, which acts as an 'eat-me' signal for engulfing cells. Phosphatidylserine is exposed on the apoptotic cell surface by a phospholipid scramblase activity.
positive regulation of axon extension Any process that activates or increases the frequency, rate or extent of axon extension.
positive regulation of cell population proliferation Any process that activates or increases the rate or extent of cell proliferation.
positive regulation of cytosolic calcium ion concentration Any process that increases the concentration of calcium ions in the cytosol.
positive regulation of neuron differentiation Any process that activates or increases the frequency, rate or extent of neuron differentiation.
positive regulation of peptidyl-threonine phosphorylation Any process that increases the frequency, rate or extent of peptidyl-threonine phosphorylation. Peptidyl-threonine phosphorylation is the phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.
regulation of cytosolic calcium ion concentration Any process involved in the maintenance of an internal steady state of calcium ions within the cytosol of a cell or between the cytosol and its surroundings.
regulation of membrane hyperpolarization Any process that modulates the frequency, rate or extent of membrane hyperpolarization.

20 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
O18784 TRPC1 Short transient receptor potential channel 1 Bos taurus (Bovine) PR
P79100 TRPC4 Short transient receptor potential channel 4 Bos taurus (Bovine) PR
P19334 trp Transient receptor potential protein Drosophila melanogaster (Fruit fly) PR
P48994 trpl Transient-receptor-potential-like protein Drosophila melanogaster (Fruit fly) PR
Q9Y210 TRPC6 Short transient receptor potential channel 6 Homo sapiens (Human) PR
Q13507 TRPC3 Short transient receptor potential channel 3 Homo sapiens (Human) PR
Q9UBN4 TRPC4 Short transient receptor potential channel 4 Homo sapiens (Human) PR
P48995 TRPC1 Short transient receptor potential channel 1 Homo sapiens (Human) PR
Q9HCX4 TRPC7 Short transient receptor potential channel 7 Homo sapiens (Human) PR
Q9UL62 TRPC5 Short transient receptor potential channel 5 Homo sapiens (Human) PR
Q61143 Trpc6 Short transient receptor potential channel 6 Mus musculus (Mouse) PR
Q9WVC5 Trpc7 Short transient receptor potential channel 7 Mus musculus (Mouse) PR
Q9R244 Trpc2 Short transient receptor potential channel 2 Mus musculus (Mouse) PR
Q61056 Trpc1 Short transient receptor potential channel 1 Mus musculus (Mouse) PR
Q9QUQ5 Trpc4 Short transient receptor potential channel 4 Mus musculus (Mouse) PR
Q9QZC1 Trpc3 Short transient receptor potential channel 3 Mus musculus (Mouse) PR
Q9QX01 Trpc1 Short transient receptor potential channel 1 Rattus norvegicus (Rat) PR
O35119 Trpc4 Short transient receptor potential channel 4 Rattus norvegicus (Rat) PR
Q9JMI9 Trpc3 Short transient receptor potential channel 3 Rattus norvegicus (Rat) PR
Q9R283 Trpc2 Short transient receptor potential channel 2 Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MAQLYYKKVN YSPYRDRIPL QIVRAETELS AEEKAFLSAV EKGDYATVKQ ALQEAEIYYN
70 80 90 100 110 120
VNINCMDPLG RSALLIAIEN ENLEIMELLL NHSVYVGDAL LYAIRKEVVG AVELLLSYRK
130 140 150 160 170 180
PSGEKQVPTL MMDTQFSEFT PDITPIMLAA HTNNYEIIKL LVQKRVTIPR PHQIRCNCVE
190 200 210 220 230 240
CVSSSEVDSL RHSRSRLNIY KALASPSLIA LSSEDPILTA FRLGWELKEL SKVENEFKAE
250 260 270 280 290 300
YEELSQQCKL FAKDLLDQAR SSRELEIILN HRDDHSEELD PQKYHDLAKL KVAIKYHQKE
310 320 330 340 350 360
FVAQPNCQQL LATLWYDGFP GWRRKHWVVK LLTCMTIGFL FPMLSIAYLI SPRSNLGLFI
370 380 390 400 410 420
KKPFIKFICH TASYLTFLFM LLLASQHIVR TDLHVQGPPP TVVEWMILPW VLGFIWGEIK
430 440 450 460 470 480
EMWDGGFTEY IHDWWNLMDF AMNSLYLATI SLKIVAYVKY NGSRPREEWE MWHPTLIAEA
490 500 510 520 530 540
LFAISNILSS LRLISLFTAN SHLGPLQISL GRMLLDILKF LFIYCLVLLA FANGLNQLYF
550 560 570 580 590 600
YYETRAIDEP NNCKGIRCEK QNNAFSTLFE TLQSLFWSVF GLLNLYVTNV KARHEFTEFV
610 620 630 640 650 660
GATMFGTYNV ISLVVLLNML IAMMNNSYQL IADHADIEWK FARTKLWMSY FDEGGTLPPP
670 680 690 700 710 720
FNIIPSPKSF LYLGNWFNNT FCPKRDPDGR RRRHNLRSFT ERHADSLIQN QHYQEVIRNL
730 740 750 760 770 780
VKRYVAAMIR NSKTNEGLTE ENFKELKQDI SSFRYEVLDL LGNRKHPRRS LSTSSADFSQ
790 800 810 820 830 840
RDDTNDGSGG ARAKSKSVSF NVGCKKKACH GAPLIRTVPR ASGAQGKPKS ESSSKRSFMG
850 860 870 880 890 900
PSFKKLGLFF SKFNGQTSEP TSEPMYTISD GIAQQHCMWQ DIRYSQMEKG KAEACSQSQM
910 920 930 940 950 960
NLGEVELGEI RGAAARSSEC PLACSSSLHC ASGICSSNSK LLDSSEDVFE TWGEACDLLM
970
HKWGDGQEEQ VTTRL